Latest Gannet BioChem News & Updates

See the latest news and media coverage for Gannet BioChem. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Gannet BioChem

Specialized CDMO for polymer science in therapeutics

gannetbiochem.com
Headquarters
Huntsville, United States
Founded year
1998
Company type
Private company
Number of employees
80–200

Latest news about Gannet BioChem

Company announcements

  • Gannet BioChem

    Gannet BioChem files Type II DMF for mPEG propionaldehyde 20K

    The filing under its Arab facility supports pegfilgrastim biosimilars. CEO Shackley highlights post-acquisition progress.

  • Gannet BioChem

    Gannet BioChem welcomes Laysan Bio team post-acquisition

    They strengthen their platform and expand expertise in activated polymers and bioconjugation to support customers.

  • Gannet BioChem

    Gannet BioChem acquires Laysan Bio

    The acquisition expands activated polymer and bioconjugation capabilities, enhancing support from early development to GMP manufacturing. It aligns with Gannet BioChem's strategy.

  • Gannet BioChem

    Gannet BioChem achieves SBTi validation for climate targets

    The company commits to reducing Scope 1 and 2 GHG emissions 63% by 2035 from 2020 baseline and measuring Scope 3 emissions. CEO Nicholas Shackley highlights environmental responsibility.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Gannet BioChem

Track Gannet BioChem and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.